Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy

BACKGROUND: The prognostic/predictive value of potential vascular endothelial growth factor (VEGF) signalling biomarkers was evaluated retrospectively using samples from two randomized Phase III studies (HORIZON II and III) investigating cediranib in metastatic colorectal cancer (mCRC). METHODS: Bas...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Jürgensmeier, J M, Schmoll, H-J, Robertson, J D, Brooks, L, Taboada, M, Morgan, S R, Wilson, D, Hoff, P M
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2013
Teme:
Molecular Diagnostics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3619270/
https://ncbi.nlm.nih.gov/pubmed/23449351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.79
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki